Compare ARK Genomic Revolution ETF (ARKG) vs Intel Corp (INTC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Intel Corp — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Intel Corp trades at $106.8 (market cap $552.06B). The key difference: Intel Corp pays a 2.24% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Intel Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | INTC | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $140.94 |
52-Week Low | $23.09 | $19.31 |
Market Cap | — | $552.06B |
Volume | — | 43,552,012 |
Enterprise Value | — | $564.30B |
Dividend Yield | — | 2.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Intel (INTC) trades at $109.84, down 2.4% on the day, with a bearish technical signal but recent earnings beats. The stock shows mixed fundamentals with a high P/E of 904.17 and negative net margin of -5.9%, though operating cash flow improved to $9.70B in 2025. News highlights government support and turnaround progress, with consensus price target at $99.70.
Outlook remains cautious due to profitability challenges and competitive pressures, but long-term growth potential exists from AI and foundry expansions. Key risks include execution on capital investments and market share loss to AMD. Analyst sentiment is mixed with 36.9% buy ratings, suggesting patience for turnaround results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →
